CI:NYE-Cigna Corporation (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 212.01

Change

+4.50 (+2.17)%

Market Cap

USD 74.97B

Volume

1.37M

Average Target Price

USD 245.91 (+15.99%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Cigna Corporation provides insurance and related products and services. It operates through Health Services, Integrated Medical, International Markets, and Group Disability and Other segments. The Health Services segment provides pharmacy benefits management, specialty pharmacy services, clinical solutions, home delivery, and health management services. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health, vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to on and off the public exchanges. The International Markets segment offers supplemental health, life, and accident insurance products; and health care coverage, as well as health care benefits to mobile employees of multinational organizations. This segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, and variable universal life products. The Group Disability and Other segment provides group long-term and short-term disability, group life, accident, voluntary, and specialty insurance products, as well as related services; permanent insurance contracts to corporations to provide coverage on the lives of certain employees for the purpose of financing employer-paid future benefit obligations; and reinsurance, settlement annuity, individual life insurance, and annuity and retirement benefit business. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. Cigna Corporation has a strategic alliance with Priority Health to make health care coverage accessible to Michigan employers, their employees and families. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-12-02 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

+6.37 (+1.87%)

USD323.73B 19.60 12.79
CVS CVS Health Corporation

+2.09 (+3.09%)

USD88.40B 11.16 8.99
ANTM Anthem, Inc

+4.55 (+1.45%)

USD78.11B 16.22 N/A
HUM Humana Inc

+0.03 (+0.01%)

USD53.69B 13.00 N/A
CNC Centene Corporation

+0.97 (+1.54%)

USD36.45B 16.67 8.33
MOH Molina Healthcare, Inc

+0.84 (+0.41%)

USD12.30B 15.62 7.14
GTS Triple-S Management Corporatio..

+0.44 (+1.93%)

USD0.54B 9.95 N/A

ETFs Containing CI

Symbol Name Weight Mer Price(Change) Market Cap
ESGL Invesco ESG Revenue ETF 0.00 % 0.40 %

N/A

USD0.03B
VVAL:LSE Vanguard Global Value Fac.. 0.00 % 0.00 %

+0.24 (+0.96%)

USD0.24B
VGVL:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

-0.03 (-0.11%)

N/A
UET0:XETRA UBS ETF - Bloomberg Barcl.. 0.00 % 0.00 %

-0.07 (-0.38%)

N/A
UEF9:XETRA UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

-0.12 (-0.77%)

N/A
UEF0:XETRA UBS ETF - Bloomberg Barcl.. 0.00 % 0.23 %

-0.06 (-0.31%)

N/A
SYBR:XETRA SPDR Bloomberg Barclays 1.. 0.00 % 0.20 %

-0.17 (-0.59%)

USD0.09B
SYB1:XETRA SPDR Bloomberg Barclays U.. 0.00 % 0.20 %

N/A

USD0.02B
MJMT:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.47 (-0.63%)

USD0.35B
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.98 (-0.67%)

N/A
UEF9:F UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

-0.04 (-0.23%)

N/A
UEF0:F UBS ETF - Bloomberg Barcl.. 0.00 % 0.23 %

N/A

N/A
SYBR:F SPDR Bloomberg Barclays 1.. 0.00 % 0.20 %

N/A

USD0.09B
SYB1:F SPDR Bloomberg Barclays U.. 0.00 % 0.20 %

N/A

USD0.02B
MJMT:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.11 (-0.15%)

USD0.35B
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.92 (-0.63%)

N/A
UC98:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.20 %

+3.75 (+0.26%)

N/A
FCOR Fidelity Corporate Bond E.. 0.00 % 0.36 %

-0.15 (-0.26%)

USD0.22B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

+0.02 (+0.07%)

USD0.21B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+2.10 (+0.93%)

USD0.91B
ONEO SPDR Russell 1000 Momentu.. 0.00 % 0.20 %

-0.17 (-0.21%)

USD0.22B
SPVU Invesco S&P 500 Enhanced .. 0.00 % 0.13 %

+0.36 (+1.09%)

USD0.07B
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.37 %

+0.20 (+0.63%)

USD0.06B
HONR InsightShares Patriotic E.. 0.00 % 0.65 %

N/A

USD1.34M
FHI Federated Hermes, Inc 0.00 % 0.00 %

+0.20 (+0.74%)

N/A
JAGG JPMorgan U.S. Aggregate B.. 0.00 % 0.07 %

-0.05 (-0.18%)

USD0.70B
UC97:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.20 %

-0.08 (-0.43%)

N/A
CGAA:CA CI Global Asset Allocatio.. 0.00 % 0.90 %

+0.27 (+1.19%)

USD0.02B
BSUS:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.25 %

-5.30 (-0.45%)

N/A
JPNY:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+48.00 (+0.37%)

N/A
UC76:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

-0.08 (-0.41%)

N/A
UC85:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.23 %

-6.75 (-0.37%)

N/A
UC86:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

N/A

N/A
VMUS:XETRA VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

-0.30 (-0.79%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.68% 38% F 64% D
Dividend Return 0.02% 20% F N/A N/A
Total Return 3.70% 38% F 58% F
Trailing 12 Months  
Capital Gain 7.76% 38% F 68% D+
Dividend Return 0.02% 20% F N/A N/A
Total Return 7.78% 38% F 63% D
Trailing 5 Years  
Capital Gain 50.97% 38% F 72% C-
Dividend Return 0.14% 20% F N/A N/A
Total Return 51.11% 38% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 9.97% N/A N/A 79% C+
Dividend Return 0.03% N/A N/A 1% F
Total Return 9.99% N/A N/A 74% C
Risk Return Profile  
Volatility (Standard Deviation) 19.48% N/A N/A 41% F
Risk Adjusted Return 51.29% N/A N/A 69% D+
Market Capitalization 74.97B 63% D 97% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 14.57 63% D 61% D-
Price/Book Ratio 1.60 63% D 49% F
Price / Cash Flow Ratio 7.90 75% C 46% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 11.49% 38% F 73% C
Return on Invested Capital 8.19% 25% F 64% D
Return on Assets 3.64% 25% F 70% C-
Debt to Equity Ratio 70.21% 38% F 49% F
Technical Ratios  
Short Ratio 1.63 100% A+ 57% F
Short Percent 1.03% 88% B+ 82% B-
Beta 0.71 63% D 72% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.